Medical_Imaging
LightNews LightNews
banner
puritanuj.bsky.social
Medical_Imaging
@puritanuj.bsky.social
45 followers 58 following 64 posts
Medical Imaging: PET, CT, MRI, Histopathology, Radiotherapy.

Areas: Head & neck cancer, Rectal cancer, Prostate cancer, Lymphoma, Osteoporosis, Lung injury.
Posts Replies Media Videos
puritanuj.bsky.social
New Perspective on Voxel-Based Analysis (VBA) in Radiotherapy. www.mdpi.com/2077-0383/14...
October 18, 2025 at 11:19 AM
puritanuj.bsky.social
How do parameter choices impact dose-toxicity predictions in #radiotherapy? A #pcuk funded investigation tried to question the question and the findings may surprise you. Read the full study: www.sciencedirect.com/science/arti...
October 17, 2025 at 7:13 PM
puritanuj.bsky.social
Comparing Radiation Effects on the Bladder and Rectum in Prostate Cancer Patients: With and Without Adjusting for Pre-Treatment Side Effects #prostatecancer #radiotherapy #toxicities #biomarkers #predictionmodels #VBA #IBDM #OAR #bladder #rectum ssrn.com/abstract=502...
Puri, Tanuj and Choudhury, Ananya and Dunning, Alison M. and Farcy Jacquet, Marie-Pierre and de Ruysscher, D. and Azria, David and Avuzzi, Barbara and Gioscio, Eliana and West, Catharine ML and McWilliam, Alan and Kerns, Sarah and Shortall, Jane and Lambrecht, Maarten and Sperk, Elena and Seibold, Petra and van Herk, Marcel and Chang-Claude, Jenny and Webb, Adam and Veldeman, Liv and Vega, Ana and Rosenstein, Barry S. and J Talbot, Christopher and Vasquez Osorio, Eliana and rancati, tiziana and Morris, Andrew P. and Green, Andrew and Hoskin, Peter J., Comparison of Dose-Response Maps of the Bladder and Rectum in Prostate Cancer Patients Undergoing Radiotherapy With and Without Baseline Toxicity Normalization (November 18, 2024). Available at SSRN: https://ssrn.com/abstract=5028585 or http://dx.doi.org/10.2139/ssrn.5028585
January 26, 2025 at 9:30 AM
puritanuj.bsky.social
Sensitivity of Bladder Dose-Response to Model Parameters in Prostate Cancer Radiotherapy #CancerResearch #Radiotherapy #ProstateCancer ssrn.com/abstract=510...
Puri, Tanuj and Choudhury, Ananya and Dunning, Alison M. and Farcy Jacquet, Marie-Pierre and de Ruysscher, D. and Azria, David and Avuzzi, Barbara and West, Catharine ML and McWilliam, Alan and Kerns, Sarah and Lambrecht, Maarten and Sperk, Elena and Seibold, Petra and van Herk, Marcel and Chang-Claude, Jenny and Webb, Adam and Veldeman, Liv and Vega, Ana and Rosenstein, Barry S. and J Talbot, Christopher and Vasquez Osorio, Eliana and rancati, tiziana and Hoskin, Peter J., Sensitivity of Bladder Dose-Response to Model Parameters in Prostate Cancer Radiotherapy (January 18, 2025). Available at SSRN: https://ssrn.com/abstract=5105722
January 21, 2025 at 1:02 PM
puritanuj.bsky.social
What are the 6 ways to quantify [18F]NaF PET-CT imaging? #18FNaF #nucmed #molrad #nuclearmedicine #nuclearradiology #molecularimaging #petct #petmri #precisionmedicine #precisionimaging #BoneHealth #HealthyBones #BoneResearch #ImagingInnovation #EarlyDetection #StrongBones
Puri T, Blake GM, Frost ML, Siddique M, Moore AE, Marsden PK, Cook GJ, Fogelman I, Curran KM. Comparison of six quantitative methods for the measurement of bone turnover at the hip and lumbar spine using 18F-fluoride PET-CT. Nucl Med Commun. 2012 Jun;33(6):597-606. doi: 10.1097/MNM.0b013e3283512adb. PMID: 22441132. Puri, T. (2011). Bone metabolism measured with six quantification methods using 18F-PET, World Molecular Imaging Congress. In World Molecular Imaging Congress, 7-10 Sept 2011, San Diego, California, USA. https://lnkd.in/e7XvCEaR
January 12, 2025 at 8:58 AM
puritanuj.bsky.social
What are precision errors, and what do they mean in [18F]NaF PET imaging? #18FNaF #nucmed #molrad #nuclearmedicine #nuclearradiology #molecularimaging #petct #petmri #precisionmedicine #precisionimaging #boneimaging
doi: 10.21037/qims.2018.01.02
Blake GM, Puri T, Siddique M, Frost ML, Moore AEB, Fogelman I. Site specific measurements of bone formation using [18F] sodium fluoride PET/CT. Quant Imaging Med Surg. 2018 Feb;8(1):47-59. doi: 10.21037/qims.2018.01.02. PMID: 29541623; PMCID: PMC5835654.
January 10, 2025 at 9:54 AM
puritanuj.bsky.social
When using [18F]NaF PET, which is the most effective parameter to assess treatment response? #18FNaF #nucmed #molrad #nuclearmedicine #nuclearradiology #molecularimaging #petct #petmri #precisionmedicine #precisionimaging #ImagingInnovation doi: 10.21037/qims.2018.01.02
Blake GM, Puri T, Siddique M, Frost ML, Moore AEB, Fogelman I. Site specific measurements of bone formation using [18F] sodium fluoride PET/CT. Quant Imaging Med Surg. 2018 Feb;8(1):47-59. doi: 10.21037/qims.2018.01.02. PMID: 29541623; PMCID: PMC5835654.
January 9, 2025 at 9:17 AM
puritanuj.bsky.social
[18F]NaF vs [18F]FDG PET-CT for Detection of Skull-Base Invasion and Osseous Metastases in Nasopharyngeal Carcinoma #nuclearmedicine #nuclearradiology #molecularimaging #petct #petmri #precisionmedicine #precisionimaging #cancer doi: 10.1155/2018/8271313
Zhang Y, Chen Y, Huang Z, Zhang L, Wan Q, Lei L. Comparison of 18F-NaF PET/CT and 18F-FDG PET/CT for Detection of Skull-Base Invasion and Osseous Metastases in Nasopharyngeal Carcinoma. Contrast Media Mol Imaging. 2018 Sep 5;2018:8271313. doi: 10.1155/2018/8271313. PMID: 30254551; PMCID: PMC6145050.
January 8, 2025 at 10:32 AM
puritanuj.bsky.social
[18F]FDG+[18F]NaF PET-CT vs [18F]FDG PET-CT imaging for detection of malignancy #18FNaF #nucmed #molrad #nuclearmedicine #nuclearradiology #molecularimaging #petct #petmri #precisionmedicine #precisionimaging #CancerResearch #BoneRemodeling doi: 10.1007/s00259-011-1971-1
Lin, F.I., Rao, J.E., Mittra, E.S. et al. Prospective comparison of combined 18F-FDG and 18F-NaF PET/CT vs. 18F-FDG PET/CT imaging for detection of malignancy. Eur J Nucl Med Mol Imaging 39, 262–270 (2012).
January 7, 2025 at 10:09 AM
puritanuj.bsky.social
Cocktail [18F]NaF and [18F]FDG PET-CT Scan for Evaluation of Malignancy #18FNaF #nucmed #molrad #nuclearmedicine #nuclearradiology #molecularimaging #petct #petmri #precisionmedicine #precisionimaging doi: 10.2967/jnumed.108.058339
Iagaru A, Mittra E, Yaghoubi SS, Dick DW, Quon A, Goris ML, Gambhir SS. Novel strategy for a cocktail 18F-fluoride and 18F-FDG PET/CT scan for evaluation of malignancy: results of the pilot-phase study. J Nucl Med. 2009 Apr;50(4):501-5. doi: 10.2967/jnumed.108.058339. Epub 2009 Mar 16. PMID: 19289439.
January 5, 2025 at 10:46 AM
puritanuj.bsky.social
Strontium Ranelate Keeps Bones Strong: How It Supports Healthy Bone Formation in Osteoporotic Women! #BoneHealth #HealthyBones #Osteoarthritis #BoneResearch #ImagingInnovation #StrongBones #BoneWellness #BoneStrength #BoneRemodeling #EarlyDetection doi: 10.1007/s00198-009-1005-z
Boivin G, Farlay D, Khebbab MT, Jaurand X, Delmas PD, Meunier PJ. In osteoporotic women treated with strontium ranelate, strontium is located in bone formed during treatment with a maintained degree of mineralization. Osteoporos Int. 2010 Apr;21(4):667-77. doi: 10.1007/s00198-009-1005-z. Epub 2009 Jul 14. PMID: 19597910.
January 3, 2025 at 9:42 AM
puritanuj.bsky.social
When to perform [18F]NaF PET scan for estimating bone metabolism post-treatment? #18FNaF #nucmed #molrad #nuclearmedicine #nuclearradiology #molecularimaging #petct #petmri #precisionmedicine #precisionimaging doi: 10.1210/jcem.79.6.7989477
Garnero P, Shih WJ, Gineyts E, Karpf DB, Delmas PD. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. J Clin Endocrinol Metab (1994) 79(6):1693–700. doi: 10.1210/jcem.79.6.7989477
January 2, 2025 at 11:22 AM
puritanuj.bsky.social
Happy New Year to All #18FNaF #nucmed #molrad #nuclearmedicine #nuclearradiology #molecularimaging #petct #petmri #precisionmedicine #precisionimaging #BoneHealth #HealthyBones #Osteoarthritis #BoneResearch #ImagingInnovation #cancer #prostatecancer #breastcancer #metastasis
January 1, 2025 at 10:30 AM
puritanuj.bsky.social
[18F]NaF PET as a Way to Track Treatment Response in Bone Metastases from Prostate Cancer #18FNaF #nucmed #molrad #nuclearmedicine #nuclearradiology #molecularimaging #petct #petmri #precisionmedicine #precisionimaging
#cancer #prostat #prostatecancer DOI: 10.1186/2191-219X-1-4
Cook, G.J., Parker, C., Chua, S. et al. 18F-fluoride PET: changes in uptake as a method to assess response in bone metastases from castrate-resistant prostate cancer patients treated with 223Ra-chloride (Alpharadin). EJNMMI Res 1, 4 (2011). https://lnkd.in/es9x4ckh
December 30, 2024 at 11:36 AM
puritanuj.bsky.social
[18F]NaF vs [18F]FDG PET-CT in Detecting Occult Metastatic Disease in Prostate Cancer #18FNaF #nucmed #molrad #nuclearmedicine #nuclearradiology #molecularimaging #petct #petmri #precisionmedicine #precisionimaging #cancer #prostatecancer doi: 10.1053/j.semnuclmed.2014.07.008
Jadvar H, Desai B, Conti PS. Sodium 18F-fluoride PET/CT of bone, joint, and other disorders. Semin Nucl Med. 2015 Jan;45(1):58-65. doi: 10.1053/j.semnuclmed.2014.07.008.
December 29, 2024 at 5:10 PM
puritanuj.bsky.social
[18F]FDG vs [18F]NaF PET-CT in breast cancer with bone metastases #18FNaF #nucmed #molrad #nuclearmedicine #nuclearradiology #molecularimaging #petct #petmri #precisionmedicine #precisionimaging #ImagingInnovation
doi: 10.3892/ol.2024.14679
Hu H, Hu X, Liang Z, Yang W, Li S, Li D, Cai J. Diagnostic performance of 18F‑FDG PET/CT vs. 18F‑NaF PET/CT in breast cancer with bone metastases: An indirect comparative meta‑analysis. Oncol Lett. 2024 Sep 12;28(5):546. doi: 10.3892/ol.2024.14679. PMID: 39319212; PMCID: PMC11420642.
December 28, 2024 at 1:58 PM
puritanuj.bsky.social
[18F]NaF PET for Detecting Bone Metastases in Prostate Cancer Patients #18FNaF #nucmed #molrad #nuclearmedicine #nuclearradiology #molecularimaging #petct #precisionmedicine #precisionimaging #BoneImaging #BoneRemodeling #EarlyDetection #prostatecancer #cancer jnm.snmjournals.org/content/47/2...
Even-Sapir E, Metser U, Mishani E, Lievshitz G, Lerman H, Leibovitch I. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT. J Nucl Med. 2006 Feb;47(2):287-97. PMID: 16455635.
December 27, 2024 at 12:28 PM
puritanuj.bsky.social
Correlation between [18F]NaF PET and bone histomorphometry in renal osteodystrophy #18FNaF #nucmed #molrad #nuclearmedicine #nuclearradiology #molecularimaging #petct #petmri #precisionmedicine #precisionimaging doi: 10.1016/j.bone.2020.115267
Aaltonen L, Koivuviita N, Seppänen M, Tong X, Kröger H, Löyttyniemi E, Metsärinne K. Correlation between 18F-Sodium Fluoride positron emission tomography and bone histomorphometry in dialysis patients. Bone. 2020 May;134:115267. doi: 10.1016/j.bone.2020.115267. Epub 2020 Feb 11. PMID: 32058018.
December 26, 2024 at 9:43 AM
puritanuj.bsky.social
[18F] NaF PET Ki vs SUV? #18FNaF #nucmed #molrad #nuclearmedicine #nuclearradiology #molecularimaging #petct #precisionmedicine #precisionimaging #BoneResearch #ImagingInnovation #BoneImaging #BoneRemodeling #EarlyDetection #ArthritisAwareness doi: 10.1002/mp.16125
Puri T, Frost ML, Moore AEB, Cook GJR, Blake GM. Input function and modeling for determining bone metabolic flux using [18 F] sodium fluoride PET imaging: A step-by-step guide. Med Phys. 2023 Apr;50(4):2071-2088. doi: 10.1002/mp.16125. Epub 2022 Dec 17. PMID: 36433629.
December 25, 2024 at 9:49 AM
puritanuj.bsky.social
Role of [18F]NaF PET-CT in Diagnosing Bone Metastases #18FNaF #nucmed #molrad #nuclearmedicine #nuclearradiology #molecularimaging #petct #petmri #precisionmedicine #precisionimaging #cancer #metastases #bone doi: 10.1016/j.jbo.2015.08.002
Araz M, Aras G, Küçük ÖN. The role of 18F-NaF PET/CT in metastatic bone disease. J Bone Oncol. 2015 Sep 16;4(3):92-7. doi: 10.1016/j.jbo.2015.08.002. PMID: 26587375; PMCID: PMC4648995.
December 24, 2024 at 11:23 AM
puritanuj.bsky.social
[18F]NaF PET for Detecting Bone Metastases in Breast Cancer #18FNaF #nucmed #molrad #nuclearmedicine #nuclearradiology #molecularimaging #petct #petmri #precisionmedicine #precisionimaging #cancer #breastcancer doi.org/10.1007/s002...
Petrén-Mallmin, M., Andréasson, I., Ljunggren, Ö. et al. Skeletal metastases from breast cancer: uptake of 18F-fluoride measured with positron emission tomography in correlation with CT. Skeletal Radiol 27, 72–76 (1998). https://doi.org/10.1007/s002560050340
December 23, 2024 at 8:03 AM
puritanuj.bsky.social
[18F]NaF PET is more accurate for detecting bone spread than planar bone scans or SPECT #18FNaF #nucmed #molrad #nuclearmedicine #nuclearradiology #molecularimaging #petct #precisionmedicine #precisionimaging #BoneResearch #ImagingInnovation #BoneImaging
jnm.snmjournals.org/content/42/1...
Schirrmeister H, Glatting G, Hetzel J, Nüssle K, Arslandemir C, Buck AK, Dziuk K, Gabelmann A, Reske SN, Hetzel M. Prospective evaluation of the clinical value of planar bone scans, SPECT, and (18)F-labeled NaF PET in newly diagnosed lung cancer. J Nucl Med. 2001 Dec;42(12):1800-4. PMID: 11752076. https://jnm.snmjournals.org/content/42/12/1800.long
December 22, 2024 at 10:26 AM
puritanuj.bsky.social
[18F]NaF PET in differentiated thyroid carcinoma
#18FNaF #nucmed #molrad #nuclearmedicine #nuclearradiology #molecularimaging #petct #petmri #precisionmedicine #precisionimaging #BoneHealth #BoneResearch #BoneImaging #BoneRemodeling doi: 10.1259/bjr.20130444
Ota N, Kato K, Iwano S, Ito S, Abe S, Fujita N, et al. Comparison of 18F-fluoride PET/CT, 18F-FDG PET/CT and bone scintigraphy (planar and SPECT) in detection of bone metastases of differentiated thyroid cancer: a pilot study. Br J Radiol 2014;87:20130444.
December 21, 2024 at 9:38 AM
puritanuj.bsky.social
Special Issue Information (Submission Deadline: 20 May 2025) #18FNaF #nucmed #molrad #nuclearmedicine #nuclearradiology #molecularimaging #petct #petmri #precisionmedicine #precisionimaging #BoneHealth #BoneResearch #BoneImaging #BoneRemodeling #EarlyDetection www.mdpi.com/journal/jcm/...
December 20, 2024 at 9:25 AM
puritanuj.bsky.social
[18F]NaF PET for Detecting Bone Spread in Head & Neck Cancer #18FNaF #nucmed #molrad #nuclearmedicine #nuclearradiology #molecularimaging #petct #petmri #precisionmedicine #precisionimaging #BoneHealth #BoneResearch #ImagingInnovation doi: 10.2967/jnumed.112.104893
Chan SC, Wang HM, Ng SH, Hsu CL, Lin YJ, Lin CY, Liao CT, Yen TC. Utility of 18F-fluoride PET/CT and 18F-FDG PET/CT in the detection of bony metastases in heightened-risk head and neck cancer patients. J Nucl Med. 2012 Nov;53(11):1730-5. doi: 10.2967/jnumed.112.104893. Epub 2012 Sep 7. PMID: 22961077.
December 19, 2024 at 11:01 AM